DFCM
ATOS icon

Dark Forest Capital Management’s Atossa Therapeutics ATOS Stock Holding History

Dark Forest Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-680
Closed -$12.8K – 1082
2023
Q2 		$12.8K Buy
+680
New +$8.25K ﹤0.01% 998
2022
Q1 		– Sell
-234
Closed -$6K – 1270
2021
Q4 		$6K Buy
+234
New +$8.56K ﹤0.01% 1082

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dark Forest Capital Management's ATOS Position: Q3 2023 in Review

Dark Forest Capital Management sold out of Atossa Therapeutics (ATOS) in Q3 2023, closing a stake of 680 shares — an estimated $12.8K sold.

Dark Forest Capital Management first reported a position in ATOS in Q4 2021 and held it in 2 quarters. The position peaked at $12.8K in Q2 2023. 54 funds tracked by Wall St. Rank hold ATOS as of Q3 2023.

  • Dark Forest Capital Management reported no remaining Atossa Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 680 Atossa Therapeutics shares in Q3 2023, an estimated $12.8K.
  • Dark Forest Capital Management first reported a position in Atossa Therapeutics in Q4 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's Atossa Therapeutics position peaked at $12.8K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2023.

Based on Dark Forest Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.